Stock Events

Stock Events

Nektar Therapeutics (NKTR) Q2 2026 Earnings

7MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-3.6

-2.93

-2.25

-1.58

Details

Expected EPS

-1.582347

Actual EPS

-1.82

Surprise EPS

-0.24

Surprise Percent

+15.02%

Description

Nektar Therapeutics (NKTR) has reported earnings of -1.82 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.